From: Intractable thrombocytopenia in a patient with atypical ataxia-telangiectasia: a case report
Tests | Examination results at each admission (age matched normal values) | |||
---|---|---|---|---|
The first (11 months) | The second (14 months) | The third (19 months) | The fourth (2 years) | |
Complete blood count | ||||
White blood cell count (×109/L) | 17.19 (4.80–14.60) | 5.52 (5.50–13.60) | 4.45 (5.50–13.60) | 6.89 (4.90–12.70) |
Red blood cell count (×1012/L) | 4.85 (4.00−5.50) | 4.40 (4.10–5.50) | 4.56 (4.10–5.50) | 4.93 (4.10–5.50) |
Hemoglobin (g/L) | 131 (97–141) | 115 (104–143) | 120 (104–143) | 128 (115–150) |
Platelet count (×109/L) | 339 (190–579) | 213 (191–516) | 42 (191–516) | 28 (187–475) |
Mean platelet volume (fL) | 8.20 (9.00–13.00) | 8.60 (7.00–11.00) | NA | NA |
Plateletcrit (%) | 0.280 (0.108–0.282) | 0.182 (0.108–0.282) | NA | NA |
Lymphocyte count/µL | 2940 (2500–9000) | 1160 (2700–9100) | 4961 (2700–9100) | 1730 (2000–6500) |
B cells (n, %) | NA | NA | 281 (461–1456), 5.66% (13.23%−26.39%) | NA |
T cells (n, %) | NA | 888 (1600–6000) | 2821 (1794–4247), 56.86% (53.88%−72.87%) | NA |
CD4+ (n, %) | NA | 510 (1020–4000) | 570 (902–2253), 11.49% (24.08%−42.52%) | NA |
CD8+ (n, %) | NA | 332 (570–2100) | 1719 (580–1735), 34.63% (19.00%−32.51%) | NA |
CD4+/CD8 + ratio | NA | 1.54 (1.00−3.80) | 0.33 (0.90–2.13) | NA |
NK cells (n, %) | NA | NA | 1814 (270–1053), 36.56% (7.21%−20.90%) | NA |
Serum immunoglobulin | ||||
IgG (g/L) | 7.48 (2.32–14.11) | 5.45 (4.53–9.16) | 6.26 (4.53–9.16) | 7.19 (4.53–9.16) |
IgA (g/L) | 0.01 (0−0.83) | 0.07 (0.20−1.00) | 0.02 (0.20−1.00) | 0.10 (0.20−1.00) |
IgM (g/L) | 0.60 (0−1.45) | 0.68 (0.19–1.46) | 0.76 (0.19–1.46) | 0.86 (0.19–1.46) |
IgE (IU/mL) | < 0.010 (0−100.00) | 5.30 (0−100.00) | 13.54 (0−100.00) | 5.35 (0−100.00) |